Screener
Xeris Biopharma Holdings, Inc. XERS Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s price / sales?
- Xeris Biopharma Holdings, Inc. (XERS) reported price / sales of 4.1× in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s price / sales changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s price / sales increased by 34.4% year-over-year, from 3× to 4.1×.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s price / sales?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s price / sales has grown at a -11.8% compound annual growth rate (CAGR), from 7.4× to 4.5×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Xeris Biopharma Holdings, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude